Abstract
The primary objective of this review was to assess the size and consistency of Royal Jelly (RJ) effect on serum lipids in experimental animals and humans. The data from animal studies were pooled, where possible, and statistically evaluated by Student's t-test. Meta-analysis was used for the evaluation of human trials. It was found that RJ significantly decreased serum and liver total lipids and cholesterol levels in rats and rabbits and also retarded the formation of atheromas in the aorta of rabbits fed a hyperlipemic diet. Meta-analysis of the controlled human trials of RJ to reduce hyperlipidemia showed a significant reduction in total serum lipids and cholesterol levels and normalization of HDL and LDL as determined from decrease in β/α lipoproteins. The best available evidence suggests that RJ at approximately 50 to 100 mg per day, decreased total serum cholesterol levels by about 14%, and total serum lipids by about 10% in the group of patients studied.
Similar content being viewed by others
References
Anitschnikow, N. N., A history of experimentation on arterial atherosclerosis in animals, in: Arteriosclerosis, pp. 21–44. Ed. E. V. Cowdry. Charles C. Thomas, Springfield, Illinois 1967.
Anitschnikow, N. N., Experimental arteriosclerosis in animals, in: arteriosclerosis a Survey of the Problem, pp. 271–322. Ed. E. V. Cowdry. Mac Millan, New York 1967.
Armstrong, M. L., Regression of atherosclerosis. Atheroscl. Rev.1 (1976) 137–82.
Bechteeva, T. T., Treatment of stenocardia with royal jelly. Inf. Bjul. o Mat. Mol.3 (1962) 109.
Belong, R. P., and Masek, J. A., The effect of royal jelly of bees for treatment of cerebral atherosclerosis. Vrach. Delo8 (1971) 26–28.
Beselkoev, T. I., Pathol. fiziologia Serd.-sosud. syst. p 211. Tbilisi 1964.
Brown, G., Albers, J. J., Fisher, L. D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med.323 (1990) 1289–98.
Butcher, R. W., and Baird, C., Effect of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. J. biol. Chem.243 (1968) 1705–12.
DeCarli, H. O., Cornejo, L. G., Castelletto, R., et al. Acción de la jelea real, piridinol carbamate y heparinoides sinteticos sobre la aterosclerosis experimental. Prensa méd. argent.59 (1972) 916–23.
Fosati, C., Sulle possibilita terapeutiche della ‘Gelatina reale’. Clinica terap.62 (1972) 377–87.
Greengard, P., The vitamins, in: Pharmacological Basis of Therapeutics, pp. 1643–1646. Eds. L. S. Goodman and D. Gillman. Collier-Mac Millan Canada Ltd, Toronto 1970.
Hammerl, H., and Pichler, O., Untersuchungen über die Wirkung des Weiselfuttersaftes auf den alternden Menschen unter besonderer Berücksichtigung des Cholesterin-Stoffwechsels. Int. J. prohyl. Med. SocHyg./Wien2 (1958) 69–71.
Hammerl, H., and Pichler, O., Zur Therapie mit Apifortyl. Medsche Klin.45 (1960) 2015–21.
Hammerl, H., and Pichler, O., Vorläufiger Bericht über die Behandlung der Arteriosclerose mit Gelee Royale-Holzinger. Z. Med.13/14 (1957) 364.
Hanza, S. M., Aod El-Wahab, S. M., Shehata, M. M., and Mohamed, T. R., Investigation of Royal Jelly Part I: Vitamin content of Royal Jelly and effect on hepatic vitamin level in male and female rats. Egypt. J. pharm. Sci.20 (1979) 365–373.
Hiyamuta, K., Toshima, H., Koga, Y., et al., Relationship between coronary risk factors and arterographic feature of coronary atherosclerosis. Jap. Circul. J.54 (1990) 442–47.
Hove, S. R., Dimick, P. S., and Benton, A. W., Composition of freshly harvested and commercial Royal Jelly. J. apic. Res.24 (1985) 52–61.
Illingworth, D. R., and Schmidt, E. B., The influence of dietary n-3 fatty acids on plasma lipids and lipoproteins. Ann. N.Y. Acad. Sci.676 (1993) 60–69.
Ingelfinger, J. A., Mosteller, F., Thibodean, L. A., and Ware, J. H., Biostatistics in Clinical Medicine, McGraw Hill Inc., New York 1994.
Jacoli, G., and Nobili, F., Ricerche su un principo ad azione parasimpaticomimetica della Gelatina Reale. Quad. Nutr.17 (1957) 91.
Kaczor, M., Koltek, A., and Matuszewski, J., The effect of Royal Jelly on blood lipids in atheromatic subjects. Polski Tygod. lek.17 (1962) 140–44.
Kadyseva, N., The use of Royal Jelly for treatment of various clinical forms of atherosclerosis. Inf. Bjul. o Mat. Mol.3 (1962) 90.
Kalinin, A. P., Effect of royal jelly and bee venom on some endocrine glands. Problem Endokr. Gormonoter.8 (1962) 119–123.
Lecker, G., Capella, P., Conte, L. S., Ruini, F., and Giordani, G., Components of Royal Jelly II. The lipid fracion, hydrocarbons and sterols. J. apic. Res.21 (1982) 178–184.
Ling, S. S., Zhou, H. P., Tang, C. P., Gzy Tian and Sun, W. L., The physiological disposotion of 10-hydroxydecenoic acid (10 HDA) in rats and mice. Acta. pharmac. sin.21 (1982) 115–121.
Loscalzo, J., Regression of coronary atherosclerosis. Science323 (1990) 1337–39.
Lupachev, V. F., K. farmakologii Apilaka. Farmak. Toks.26 (1963) 333–8.
Mach, W. J., Hodis, H. N., and Blankenhorn, D. H., Regression of atherosclerosis: A report from two clinical trials. Atheroscl. Rev.25 (1993) 301–9.
Madar, J., Maly, E., Neubauer, A., Nicak, A., Zapaticka, J., and Kocis, J., Einfluss des Mutterbreies der Bienen (Gelee Royale) und des Heparins auf die experimentelle Atherosklerose der Kaninchen. Z. Altersforsch.18 (1965) 109–14.
Madar, J., Maly, E., Neubauer, E., and Moscovic, F., Einfluss des Bienenmutterbreies (Gelée Royale) auf den Cholesterolspiegel auf die Totallipide im Serum und auf die fibrinolytische Aktivität des Plasmas der an Atherosklerose leidenden älteren Menschen. Z. Altersforsch.18 (1965) 103–8.
Meada, T., Kurota, H., and Motoyoshi, K., Effect of Royal Jelly and 10-hydroxy decenoic acid on the sebaceous glands of hamsters. Nippon Gakkai Zasshi98 (1988) 469–475.
Makarova, V. G., The effect of course-vise administration of different doses of Apilak upon some lipid metabolism indices. Farmak. Toks.32 (1969) 63–5.
Marmot, M. G., Hypercholesteremia a public, health problem, Atheroscler. Rev.18 (1988) 95–108.
Matuszewski, J., and Kaczor, M., Effect of Royal Jelly on mammals. Acta. physiol. pol.5 (1961) 745.
Mishenko, E. D., The use of Royal Jelly preparation in therapy of some cardiovascular diseases, in: Serd. Sosud. Zabolevanija i bolezni obmena vescestv, p. 63. Nauka, Moskva 1964.
Mormone, V., and Nunziata, B., in: L'action de al Gelee Royale sur animaux superieurs et sur l'Home. Annls Abeille3 (1959) 223.
Mullen, B., and Rosenthal, R., Basic Meta-analysis: Procedures and Programs. Lawrence Erlbaum Assoc., Hillsdal, New Jersey 1985.
Nakajin, S., Okiyama, K., Yamashita, S., Akiama, Y., and Shinoda, M., Effect of royal jelly on experimental hypercholesteremia in rabbits. Shoyakugaku Zasshi36 (1982) 65–69.
Nemanova, S. B., Treatment of stenocardia with royal jelly, p. 13. Inf. Bjul. o Mat. Mol. I, Rjazan1 (1959) 13.
O'Brien, K. D., Xue-Qiao, Zhao, Albers, J. J., and Brown, B. G., A review of the familial atherosclerosis treatment study: Implications for the regression of coronary atherosclerosis and prevention of clinical cardiovascular events. Atheroscl. Rev.25 (1993) 311–19.
Ornish, D., Regression of coronary artery disease by a multifactorial approach: The lifestyle heart trial. Atheroscl. Rev.25 (1993) 319–29.
Pavero, A., and Caviglia, E., La pappa reale e la sua applicazione in terapia. Arch. E Maragliano di Path. e Clin.13 (1957) 1023–33.
Pejcev, P., Chadzijev, V., Nikiforov, N., et al. Results of the combined use of some bee products, honey, royal jelly and pollen to geriatric patients. Folia med. Plovdiv8 (1966) 329–33.
Pejcev, P., Beleva-Stapkova, R., and Atanasov, N., Effect of Royal Jelly on utilization of oxygen and adenosinetriphosphatase activity in the tissues of albino rats. 25 Int. Congr. Apimonia, 8–14 Sept. 1975, pp. 178–184. Grenoble, France 1975.
Pichler, P., Zur Therapie mit Apifortyl. Medsche Klin.45 (1960) 2015.
Ross, R., Hyperlipidemia and atherosclerosis. Science193 (1976) 1094–1100.
Ross, R., Cellular mechanism of atherosclerosis. Atheroscl. Rev.25 (1993) 195–200.
Russ, E. M., Eder, H. A., and Barr, D. P., Protein lipid relationship in human plasma. I. In normal individuals. Am. J. Med.11 (1951) 468–479.
Sasko, E., and Vittek, J., A short review of the composition, chronological activity and clinical use of royal jelly an active ingredient of Viat-Apinol Spofa. Farmakoter. Zpr. Spofa11 (1965) 413–428.
Schaefer, E. J., Lipid lowering agents other than anion exchange resins which affect the gastrointestinal system, in: Pharmacologic Control of Hyperlipidemia, pp. 119–132. Eds R. Fears, R. I. Levy, J. Shepherd, C. J. Packard, and N. E. Miller. Prons. Sci. Publisher, Barcelona 1986.
Schuel, R. W., and Dixon, S. E., A possible role of 10-hydroxydecenoic acid in the sterol nutrition of the larval honey bee. J. Apic. Res.21 (1982) 115–121.
Seidel, D., Significance of risk factors. Atheroscl. Rev.25 (1993) 293–99.
Shepherd, J., Packard, C. J., Pharmacologic control of plasma cholesterol: Mechanism of action of hypocholesterolemic agents. Atheroscl. Rev.18 (1988) 109–21.
Shinoda, J., Nakajin, S., Oikawa, T., et al., Biochemical studies on vasoactive factor in royal jelly. Yakugaku Zasshi98 (1978) 132–45.
Shinoda, M., Taguchi, M., Okiyama, K., et al. Gas chromatographic determination of royal jelly content in various pharmaceutical preparations. Shoyakugaku Zasshi36 (1982) 315–18.
Sitár, J., and Černochová, Z., Treatment of angina pectoris with Vita-Apinol Spofa. Some metabolic effects of the drug. Vnitr. lek.14 (1967) 1798–1805.
Svoboda, J. A., Herbert, E. W., and Thompson, M. J., Sterols of organs involved in brood food production and of Royal Jelly in honey bees. Insect. Biochem.16 (1986) 479–482.
Takahashi, K., Kiuchi, K., Endo, M., Furuno, Y., Shinozuka, T., and Hasegawa, S., Fractions actives de la gelee royale. C. r. Séan. Soc. Biol.157 (1963) 428–430.
Taylor, C. B., Patton, D. E., and Cox, G. E., Atherosclerosis in rhesus monkeys. VI. Fatal myocardial infarction in a monkey fed fat and cholesterol. Archs Pathol.76 (1963) 404–12.
Taylor, C. B., Manalo-Esterlla, P., and Cox, G. E., Atherosclerosis in rhesus monkeys. V. marked diet-induced hypercholesteremia with xanthomatosis and severe atherosclerosis. Archs Pathol.76 (1963) 239–49.
Vergoesen, A. J., Hypothesis of interactions between acetylcholine and Prostaglandin biosynthesis. Nutr. Brain5 (1979) 109.
Vinogradova, T. V., and Zajcev, G. P., Pcela i zdorovie celoveka (Bee and the health of man), Roselschozizdat, Moskva 1964.
Vittek, J., and Slomiany, Testosterone in royal jelly. Experientia40 (1984) 104–6.
Vittek, J., and Kresanek, J., A contribution to chemical investigation of royal jelly and possibilities of applying it in therapy. Acta pharm. Pharmac., Bohemoslov.10 (1965) 83–125.
Vittek, J., Effect of royal jelly on cardiovascular and respiratory systems, in: Vcelia materska kasicka (Royal jelly), pp. 257–264. Eds J. Vittek and J. Janci, SPVL, Bratislava 1968.
Vittek, J., and Sasko, E., Vita Apinol (Gelee Royale) Farmakoterap. zpravy, Spofa Suppl.2 1966.
Yamamura, T., Tajima, S., Miyake, Y., Nomura, S., Yamamoto, A., Haze, K., and Hiramori, K., Hyperlipoproteinemia as a risk factor for ischemic heart disease. Jap. Circul. J.54 (1990) 448–456.
Zaicev, G., and Poriadin, V., The use of royal jelly in the treatment of endarteritis and atherosclerosis of peripheral arteries of extremities. Inf. Bjul o Mat. Mol. III, Rjazan3 (1962) 62.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vittek, J. Effect of Royal Jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 51, 927–935 (1995). https://doi.org/10.1007/BF01921742
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01921742